Document:

exv10w1

Exhibit 10.1

Starbucks Coffee Company

PO. Box 34110

Seattle, WA 98124-1110

206/318-1575

Howard Schultz

chairman

November 6, 2008

Troy Alstead

[address]

Dear Troy:

Thank you for your contributions to the Company’s success and congratulations on your promotion to
executive vice president, chief financial officer and chief administrative officer, effective on or
about November 25, 2008.

Here are the specifics of your offer:

You will continue to be paid bi-weekly at a base salary that annualizes to $450,000.

Executive Management Bonus Plan

You will be eligible to participate in the Executive Management Bonus Plan (EMBP) for fiscal year
2009. Your bonus target will be 50% of your eligible base salary. Payout will be based on
achievement of Company, business unit/department, and individual objectives.

For more information about the bonus plans, or a copy of the plan document, please talk to your
Partner Resources generalist. Starbucks reserves the right to review, change, amend, or cancel
incentive plans at any time.

Stock Option Grant

You will be granted stock options to purchase additional shares of Starbucks common stock with an
economic value of $210,000 USD under the Key Employee Sub-Plan to the 2005 Long-Term Equity
Incentive Plan, subject to formal approval by the Compensation and Management Development Committee
of the Board of Directors. The exercise price of the options will be the regular trading session
closing price of a share of Starbucks stock on the date of the grant. The grant date of your
options will be after you assume your new role and otherwise effective in accordance with the
Company’s equity grant timing policy. The options will be non-qualified and will vest in equal
installments over a period of four (4) years, beginning on the first anniversary date of the grant,
subject to your continued employment.

As a senior executive the Company’s executive stock ownership guidelines will apply to you. The
guidelines require covered executives to achieve a minimum investment

 

 

Troy Alstead

November 6, 2008

Page 2

in Starbucks stock within five years. The minimum investment for executive vice presidents is
$750,000. A copy of the guidelines will be provided to you.

Management Deferred Compensation Plan

You will continue to be eligible to participate in the Management Deferred Compensation Plan (MDCP)
because you are on our U.S. payroll and meet the eligibility criteria. The
MDCP provides eligible partners with the opportunity to save on a tax-deferred basis. If you have
questions about the MDCP, please contact the Starbucks Savings Team at
savings@starbucks.com. You may obtain more information about the MDCP on the Savings link
at http://LifeAt.sbux.com.

Executive Life Insurance

As an executive, you and your family have a greater exposure to financial loss resulting from your
death. You will continue to receive partner life coverage equal to three times your annualized
base pay, paid for by Starbucks. You may purchase up to an additional two times your annualized
base pay (for a total of five times pay) to a maximum life insurance benefit of $2,000,000.

Executive Physical Exam

You will continue to be eligible to participate in Starbucks executive physical program. If you
have questions about this physical, please contact Kelley Hardin at (206) 318-7756.

Benefits

To understand how your new role may affect your benefits, please contact the Starbucks Partner
Contact Center at 1-866-504-7368 or your Partner Resources generalist. Please note that although
it is Starbucks intent to continue these plans, they may be amended or terminated at any time
without notice.

Insider Trading

As an executive, with access to sensitive business and financial information about the Company, you
will continue to be prohibited from trading Starbucks securities (or, in some circumstances, the
securities of companies doing business with Starbucks) from time to time in accordance with the
Company’s Insider Trading Policy and Blackout Procedures.

Coffee Hedging

As an officer of the Company, a member of the Coffee Management Group, or a partner involved in
coffee procurement and trading on behalf of the Company, you are prohibited from trading in coffee
commodity futures for your own account. If you have further questions, please contact your Partner
Resources generalist.

 

 

Troy Alstead

November 6, 2008

Page 3

As a condition of your new role, you are asked to sign a Confidentiality, Non-Solicitation and
Non-Compete Agreement (“Non-Compete Agreement”). Enclosed are two copies. Please review and sign
both copies of the Non-Compete Agreement and this letter, and return one copy of each document to
Chet Kuchinad.

In your position, you will remain employed ‘at will,’ meaning that either you or your employer can
end the employment relationship at any time, for any reason not prohibited by law.

On behalf of the entire team, I wish you the best in your new role and look forward to your
continued success. If you have any questions, please call me at 206-318-4010.

Warm regards,

/s/ Howard Schultz

Howard Schultz

chairman, president and chief executive officer

	 	 	 
	cc:

	 	partner file
	 

	 	Stock Administration (S-HR3)
	 

	 	Chet Kuchinad
	 
	 	 
	Enc.

	 	Non-Compete Agreement

I accept employment with Starbucks Corporation, and its wholly owned subsidiaries, according to the
terms set forth above.

	 	 	 	 	 
	/s/ Troy Alstead
 

Troy Alstead

	 	11/6/08
 

Dateexv4w4

Exhibit 4.4

AVANIR PHARMACEUTICALS

AMENDMENT NO. 3 TO RIGHTS AGREEMENT

     This Amendment No. 3 (this “Amendment”) to the Rights Agreement dated as of March 5, 1999, as
amended on November 30, 1999 and April 4, 2008 (the “Rights Agreement”), is entered into as of
November 11, 2008, by and between Avanir Pharmaceuticals, a California corporation (the “Company”),
and American Stock Transfer & Trust Company, a New York corporation (the “Rights Agent”).
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in
the Rights Agreement.

RECITALS

     WHEREAS, pursuant to Section 26 of the Rights Agreement, the Company may, from time to time,
supplement or amend any provision of the Rights Agreement without the approval of any holders of
Rights in order to make any changes or provisions in regard to matters or questions arising under
the Rights Agreement that the Company may deem necessary or desirable;

     WHEREAS, pursuant to Section 1.1 of the Rights Agreement, any Person who, together with all of
its Affiliates and Associates, shall be a Beneficial Owner of 15% or more of the Common Shares of
the Company then outstanding, shall be deemed an Acquiring Person; and

     WHEREAS, the Company desires to amend the Rights Agreement as set forth below to provide for
an increase in a Person’s beneficial ownership to 20% or more of the Common Shares of the Company
then outstanding before such Person shall be deemed an Acquiring Person.

AGREEMENT

     NOW, THEREFORE, in consideration of the promises and the mutual agreements herein set forth,
the parties hereby agree as follows:

1. Section 1.1 of the Rights Agreement is hereby amended and restated in its entirety to read as
follows:

“1.1. “Acquiring Person” means any Person (as such term is hereinafter defined) who
or which, together with all Affiliates and Associates (as such terms are hereinafter
defined) of that Person, shall be the Beneficial Owner (as such term is hereinafter
defined) of 20% or more of the Common Shares of the Company then outstanding but
shall not include (i) an Exempt Person (as such term is hereinafter defined) or (ii)
if, as of November 11, 2008, any Person is the Beneficial Owner of 20% or more of
the Common Shares outstanding (an “Existing Holder”), such Existing Holder shall not
be or become an “Acquiring Person” unless and until such time as such Existing
Holder shall become the Beneficial Owner of one or more additional Common Shares of
the Company (other than pursuant to a dividend or distribution paid or made by the
Company on the outstanding Common Shares in Common Shares or pursuant to a split or
subdivision of the outstanding Common Shares), unless, upon becoming the Beneficial
Owner of such additional Common Shares, such Existing Holder is not then the
Beneficial Owner of 20% or more of the Common Shares then outstanding.
Notwithstanding the foregoing, no Person shall become an “Acquiring Person” as the
result of an acquisition of Common Shares by the Company which, by reducing the
number of shares outstanding, increases the proportionate number of shares
beneficially owned by such Person to 20% or more of the Common Shares of the Company
then outstanding; provided, however, that if a

 

 

Person shall become the Beneficial Owner of 20% or more of the Common Shares of the
Company then outstanding solely by reason of share purchases by the Company and
shall, after such share purchases by the Company, become the Beneficial Owner of one
or more additional Common Shares of the Company) other than pursuant to a dividend
or distribution paid or made by the Company on the outstanding Common Shares in
Common Shares or pursuant to a split or subdivision of the outstanding Common
Shares), then such Person shall be deemed to be an “Acquiring Person” unless upon
becoming the Beneficial Owner of such additional shares of Common Stock such Person
does not beneficially own 20% or more of the shares of Common Stock then
outstanding. Notwithstanding the foregoing, if the Board of Directors of the
Company determines in good faith that a Person who would otherwise be an “Acquiring
Person,” as defined pursuant to the foregoing provisions of this Section 1.1, has
become such inadvertently (including, without limitation, because (A) such Person
was unaware that it beneficially owned a percentage of Common Stock that would
otherwise cause such Person to be an “Acquiring Person” or (B) such Person was aware
of the extent of its Beneficial Ownership of Common Stock but had no actual
knowledge of the consequences of such Beneficial Ownership under this Agreement),
and without any intention of changing or influencing control of the Company, and
such Person divests as promptly as practicable a sufficient number of Common Shares
so that such Person would no longer be an Acquiring Person, as defined pursuant to
the foregoing provisions of this Section 1.1, then such Person shall no be deemed to
be or have become an “Acquiring Person” at any time for any purposes of this
Agreement. For all purposes of this Agreement, any calculation of the number of
Common Shares outstanding at any particular time, including for purposes of
determining the particular percentage of such outstanding Common Shares of which any
Person is the Beneficial Owner, shall be made in accordance with the last sentence
of Rule 13d-3(d)(1)(i) of the General Rules and Regulations under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), as in effect on the date of
this Agreement.”

2. Section 1.14 of the Rights Agreement is hereby deleted in its entirety.

3. Section 1.42 of the Rights Agreement is hereby deleted in its entirety.

4. Section 1.43 of the Rights Agreement is hereby deleted in its entirety.

5. The first sentence of Section 3.1 of the Rights Agreement is hereby amended and restated in its
entirety to read as follows:

“Until the earlier of (i) the tenth day after the Shares Acquisition Date or (ii) the tenth
Business Day after the date of the commencement of, or first public announcement of the
intent of any Person (other than an Exempt Person) to commence, a tender or exchange offer
the consummation of which would result in any Person (other than an Exempt Person) becoming
the Beneficial Owner of Common Shares aggregating 20% or more of the then outstanding Common
Shares of the Company (the earlier of (i) and (ii) being herein referred to as the
“Distribution Date”), (x) the Rights (unless earlier expired, redeemed or terminated) will
be evidenced (subject to the provisions of Section 3.2) by the certificates for Common
Shares registered in the names of the holders thereof (which certificates for Common Shares
shall also be deemed to be Right Certificates) and not by separate certificates, and (y) the
Rights (and the right to receive certificates therefor) will be transferable only in
connection with the transfer of the underlying Common Shares.”

2

 

4. By execution of this Agreement, the Company shall not be deemed to have compromised or waived
any of its rights under the Rights Agreement.

5. Except as expressly modified herein, all terms and conditions of the Rights Agreement shall
continue in full force and effect.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

3

 

     IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of
the day and year first above written. This Amendment may be executed in one or more counterparts,
all of which shall be considered one and the same amendment, and each of which shall be deemed to
be an original.

	 	 	 	 	 
	AVANIR PHARMACEUTICALS	 	 
	 
	 	 	 	 
	By: 

Name:

	 	/s/ Christine G. Ocampo
 

Christine G. Ocampo
	 	 
	Title:

	 	Vice President, Finance	 	 
	 
	 	 	 	 
	AMERICAN STOCK TRANSFER &

TRUST COMPANY, as Rights Agent	 	 
	 
	 	 	 	 
	By: 

Name:

	 	/s/ Herbert J. Lemmer
 

Herbert J. Lemmer
	 	 
	Title:

	 	Vice President	 	 

[Signature Page to Amendment No. 3 to Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]